Clinical trial

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

NCT00348582 · Innovative Medical, Industry · Completed

Key facts

NCT number NCT00348582
Title Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
Official title Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
Lead sponsor Innovative Medical, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Cataract
Intervention type Drug
Interventions Ketorolac, Nepafenac
First posted Jul 4, 2006
Last update posted Jun 25, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies